C M Roos
Overview
Explore the profile of C M Roos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Immink R, Secher N, Roos C, Pott F, Madsen P, van Lieshout J
Eur J Appl Physiol
. 2006 Feb;
96(5):609-14.
PMID: 16470413
In the normocapnic range, middle cerebral artery mean velocity (MCA Vmean) changes approximately 3.5% per mmHg carbon-dioxide tension in arterial blood (PaCO2) and a decrease in PaCO2 will reduce the...
2.
Jonkers R, Lettinga K, Pels Rijcken T, Prins J, Roos C, van Delden O, et al.
Clin Infect Dis
. 2004 Feb;
38(5):605-11.
PMID: 14986242
Pulmonary abnormalities may persist long after the acute phase of legionnaires disease (LD). In a cohort of 122 survivors of an outbreak of LD, 57% were still experiencing an increased...
3.
Ten Tusscher G, de Weerdt J, Roos C, Griffioen R, de Jongh F, Westra M, et al.
Acta Paediatr
. 2002 Jan;
90(11):1292-8.
PMID: 11808902
Unlabelled: Perinatal exposure to Dutch background dioxin levels is rather high. Studies of calamities have shown that dioxins negatively influence the respiratory system. It was hypothesized that perinatal exposure to...
4.
Boudoulas K, Cooke G, Roos C, Bray P, Goldschmidt-Clermont P
Arch Pathol Lab Med
. 2001 Jan;
125(1):112-5.
PMID: 11151063
Background: Although estrogen has been shown to contribute to retardation of the development of coronary heart disease in premenopausal women, the efficacy of hormone replacement therapy for coronary heart disease...
5.
Douma W, Kerstjens H, Roos C, Koeter G, Postma D
Eur Respir J
. 2000 Sep;
16(2):220-5.
PMID: 10968495
Guidelines for asthma management advocate home peak expiratory flow (PEF) monitoring. It is commonly stated that PEF variability is a good proxy of bronchial hyperresponsiveness (BHR), a hallmark of asthma....
6.
Ying A, Hassanain H, Roos C, Smiraglia D, Issa J, Michler R, et al.
Cardiovasc Res
. 2000 Mar;
46(1):172-9.
PMID: 10727665
Objective: Atherosclerosis is a multigenic process leading to the progressive occlusion of arteries of mid to large caliber. A key step of the atherogenic process is the proliferation and migration...
7.
Goldschmidt-Clermont P, Roos C, Cooke G
J Thromb Thrombolysis
. 1999 Aug;
8(2):89-103.
PMID: 10436139
No abstract available.
8.
Schoonbrood D, Out T, Hart A, Habets F, Roos C, Jansen H
Eur Respir J
. 1997 Jul;
10(7):1500-6.
PMID: 9230237
In patients with asthma or chronic obstructive pulmonary disease, there is chronic airway inflammation with increased leakage of plasma proteins into the airway lumen, which can be reduced by inhaled...
9.
Uncles D, Daugherty M, Frank D, Roos C, Rich G
Anesth Analg
. 1996 Dec;
83(6):1212-7.
PMID: 8942588
Nitric oxide (NO) or endothelium-derived relaxing factor may play an important role in modulating pulmonary vascular resistance (PVR), although previous studies have produced conflicting results. Endogenous NO inhibition causes an...
10.
Frank D, Lowson S, Roos C, Rich G
J Appl Physiol (1985)
. 1996 Sep;
81(3):1316-22.
PMID: 8889769
Hypoxic pulmonary vasoconstriction (HPV) is an important mechanism for maintaining oxygenation, which may be altered by endotoxin. We determined that acute endotoxemia alters the HPV response secondary to changes in...